Profilo
Nicholas Robbins-Cherry is currently the Chief Financial Officer, Director & Vice President at Ixaka Ltd. He previously worked as the Finance Director at CACI Ltd. from 2008 to 2013 and at The Marketing Practice (UK) Ltd. from 2013 to 2014.
In 2019, he briefly served as the Secretary at Biodexa Pharmaceuticals Plc.
Posizioni attive di Nicholas Robbins-Cherry
| Società | Posizione | Inizio |
|---|---|---|
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Direttore Finanziario/CFO | 01/10/2021 |
Precedenti posizioni note di Nicholas Robbins-Cherry
| Società | Posizione | Fine |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Direttore Finanziario/CFO | 09/09/2019 |
The Marketing Practice (UK) Ltd.
The Marketing Practice (UK) Ltd. Advertising/Marketing ServicesCommercial Services Operates as a B2B marketing agency | Direttore Finanziario/CFO | 01/01/2014 |
CACI Ltd.
CACI Ltd. Data Processing ServicesTechnology Services Provides data and technology solutions | Direttore Finanziario/CFO | 01/01/2013 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
CACI Ltd.
CACI Ltd. Data Processing ServicesTechnology Services Provides data and technology solutions | Technology Services |
Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
The Marketing Practice (UK) Ltd.
The Marketing Practice (UK) Ltd. Advertising/Marketing ServicesCommercial Services Operates as a B2B marketing agency | Commercial Services |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Health Technology |
















